MKRN3 inhibits puberty onset via interaction with IGF2BP1 and regulation of hypothalamic plasticity

Lydie Naulé1, Alessandra Mancini1, Sidney A Pereira1

  • 1Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

JCI Insight
|April 24, 2023
PubMed

Insights

Makorin ring finger protein 3 (MKRN3) inhibits puberty initiation. Its absence in mice causes early puberty, impacting hypothalamic development and neuroendocrine targets like NKB and IGF2BP1.

Area of Science:

  • Neuroendocrinology
  • Developmental Biology
  • Genetics

Background:

  • Makorin ring finger protein 3 (MKRN3) is implicated as a puberty inhibitor, with loss-of-function mutations linked to central precocious puberty.
  • Prepubertal downregulation of Mkrn3 expression in the mouse hypothalamus supports its inhibitory role in puberty onset.

Purpose of the Study:

  • To elucidate the mechanisms by which MKRN3 regulates the central control of puberty initiation.
  • To investigate the impact of MKRN3 deletion on hypothalamic development, plasticity, and key neuroendocrine pathways.

Main Methods:

  • Utilized human induced pluripotent stem cell-derived hypothalamic neurons to assess MKRN3's role in gene expression.
  • Employed a mouse model with Mkrn3 deletion to study effects on puberty onset, neuroanatomy, and neuroendocrine signaling.
  • Performed proteomics and interactome analysis to identify MKRN3 targets, including NKB and IGF2BP1.

Main Results:

  • MKRN3 deletion in human iPSC-derived neurons altered genes controlling hypothalamic development and plasticity.
  • Mkrn3 deletion in mice resulted in accelerated puberty onset in females and increased dendritic spine density in the arcuate nucleus.
  • Identified neurokinin B (NKB) and insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) as direct or indirect targets of MKRN3.

Conclusions:

  • MKRN3 inhibits pubertal initiation by regulating prepubertal hypothalamic development and plasticity.
  • MKRN3 exerts its function partly through modulation of NKB and IGF2BP1 pathways.
  • These findings reveal novel mechanisms underlying the central regulation of puberty onset involving MKRN3.

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
483
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
532
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K